Building Teams that Deliver Results and Investors: What matters most and when you need each member- Michael J Weickert, PhD-03/01/2016 - 8:30am

Event Information
Event Topic: 
Building Teams that Deliver Results and Investors: What matters most and when you need each member
Event Date: 
03/01/2016 - 8:30am
Event Location: 
Sunnyvale City Council Chambers, 456 West Olive Ave., Sunnyvale, CA
Speaker Information
Event Speaker: 
Michael J Weickert, PhD
Event Speaker Title: 
Event Speaker Company: 
Wit Creek Partners
Event Speaker Bio: 

Dr. Michael Weickert has extensive experience as a CEO (7 yrs; Sonescence, SEA Medical) and entrepreneurial leader (CBO, VP) in biotechnology (Somatogen), drug delivery (Inhale, Nektar, Strategent Life Sciences, Corium, Sonescence, SciDose LLC), medical devices (SEA Medical) and pharmaceuticals (Ligand, Auspex), including raising capital, establishing and maintaining business partnerships, and leading new ventures. He personally initiated and negotiated investment rounds (Seed through Series C) and partnerships worth more than $175 Million. Michael prepared dozens of business plans and marketed programs to partners in the US and internationally (Japan, Germany, United Kingdom, Switzerland, Italy, and Israel). He has driven pharmaceutical product development through all clinical phases and engaged with the FDA and EMEA on regulatory requirements, Orphan Drug and Fast Track designations. He created an anti-infectives business unit for Nektar that placed four products in development and formed the core of the $115M pulmonary business acquisition by Novartis in 2008. At Wit Creek Partners, Dr. Weickert has prepared business and marketing plans for a Nobel Prize winner’s startup and several other Venture-backed startups and for public companies, and led development of pharmaceutical and drug delivery products. Dr. Weickert is currently an advisor for several companies and served on the screening committee for Devices and for Therapeutics for 7 years with Life Science Angels, a premier Angel group in the Bay area. Dr. Weickert received his Ph.D. in Genetics from the University of Wisconsin and worked at the National Cancer Institute of NIH. He holds numerous biotechnology and device patents and published many scientific papers in leading journals.

His public profile and endorsements are available at:
Examples of work and engagements can be viewed at:

Event Details
Event Details: 

One of the most important things investors look at in a startup or established company is the team. Do they have the skills and experience to deliver on the promise and vision of the company? Have they worked together and overcome adversity? Will they stick with it when things go wrong and pivot if they have to? Investors care so much because they have learned through experience that the weakest part of a company is often not the product idea or IP, it is the team collected to execute on product development.

This talk collects years of experience from both the investor and startup side to create a structure that helps technical founders evaluate their team characteristics against what is needed at each stage of development and against what investors will be looking for at each investment stage. The take-homes are: experience matters, network matters, success matters and trust and respect matter most of all.